- Home
- CAMT vs SLNO Comparison
CAMT vs SLNO Comparison
Compare CAMT & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAMT
- SLNO
- Stock Information
- Founded
- CAMT 1987
- SLNO 1999
- Country
- CAMT Israel
- SLNO United States
- Employees
- CAMT N/A
- SLNO N/A
- Industry
- CAMT Electronic Components
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CAMT Technology
- SLNO Health Care
- Exchange
- CAMT Nasdaq
- SLNO Nasdaq
- Market Cap
- CAMT 3.8B
- SLNO 3.8B
- IPO Year
- CAMT 2000
- SLNO 2014
- Fundamental
- Price
- CAMT $86.69
- SLNO $53.13
- Analyst Decision
- CAMT Strong Buy
- SLNO Strong Buy
- Analyst Count
- CAMT 11
- SLNO 10
- Target Price
- CAMT $96.91
- SLNO $112.50
- AVG Volume (30 Days)
- CAMT 286.2K
- SLNO 1.9M
- Earning Date
- CAMT 11-11-2025
- SLNO 11-05-2025
- Dividend Yield
- CAMT 1.58%
- SLNO N/A
- EPS Growth
- CAMT 38.64
- SLNO N/A
- EPS
- CAMT 2.73
- SLNO N/A
- Revenue
- CAMT $471,588,000.00
- SLNO $32,656,999.00
- Revenue This Year
- CAMT $17.21
- SLNO N/A
- Revenue Next Year
- CAMT $8.45
- SLNO $175.39
- P/E Ratio
- CAMT $29.72
- SLNO N/A
- Revenue Growth
- CAMT 27.88
- SLNO N/A
- 52 Week Low
- CAMT $47.41
- SLNO $41.50
- 52 Week High
- CAMT $110.73
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- CAMT 55.66
- SLNO 24.74
- Support Level
- CAMT $80.61
- SLNO $50.63
- Resistance Level
- CAMT $83.70
- SLNO $72.99
- Average True Range (ATR)
- CAMT 2.91
- SLNO 4.27
- MACD
- CAMT 0.58
- SLNO -1.03
- Stochastic Oscillator
- CAMT 79.24
- SLNO 11.49
About CAMT Camtek Ltd.
Camtek Ltd is engaged in the manufacturing of metrology and inspection equipment and software solutions for the semiconductor industry. Its systems inspect wafers for various semiconductor market segments, including Advanced Packaging, Heterogenous Integration (HI), Compound Semiconductors, Memory, and foundries among others. Geographically, it derives maximum revenue from China followed by Asia Pacific, Korea, United States, and Europe. The company's products and services include Surface Inspection, Bump Inspection and Metrology, and others.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.